SEC Company Response from AIM ImmunoTech Inc. (AIM) (CIK 0000946644) (AIM) — Sep 6, 2019
AIM ImmunoTech Inc. (AIM) (CIK 0000946644)
Date: Sept. 6, 2019 · CIK: 0000946644 · Accession: 0001493152-19-013821
AI Filing Summary & Sentiment
Show Raw Text
CORRESP
1
filename1.htm
SILVERMAN
SHIN & BYRNE PLLC
Wall
Street Plaza
22nd
Floor
88
Pine Street
NEW
YORK, NY 10005
212.779.8600
Facsimile:
212.779.8858
New
Jersey
19
Engle Street
Tenafly,
NJ 07670
(201)
567-4969
September
6, 2019
Division
of Corporation Finance
Securities
and Exchange Commission
100
F Street, NE
Washington,
DC 20549
Re:
AIM
ImmunoTech Inc. (formerly Hemispherx Biopharma, Inc.)
Registration
Statement on Form S-1
Dear
Sir or Madam:
On
behalf of AIM ImmunoTech Inc. we file herewith a registration statement on Form S-1.
Please
direct any questions or comments to the undersigned, Richard Feiner, Esq., 646 822-1170 (rfeiner@silverfirm.com)
or John Shin, Esq., 646 822-1165 (jshin@silverfirm.com).
Very
truly yours,
/s/
Richard Feiner
Richard
Feiner
cc:
AIM ImmunoTech Inc..